Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    

 SummaryChartsNewsCalendarCompanyFinancialsConsensus 
Company
Cyclacel Pharmaceuticals, Inc. is a diversified biopharmaceutical business focused in hematology and oncology based on a development pipeline of novel drug candidates.It is engaged in discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious... 
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
07/13 CYCLACEL PHARMACEUTICALS INC : ex-dividend day
07/06 CYCLACEL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form..
06/23 CYCLACEL PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Ter..
06/16 Cyclacel Regains Compliance With Nasdaq Continued Listing Requirements
06/06 Cyclacel Reports Updated Data From Its DNA Damage Response Program on Selicic..
05/31 CYCL PHAR : REVERSE SPLIT: 1 of 12
05/28 CYCLACEL PHARMACEUTICALS : Announces Reverse Stock Split
05/27 CYCLACEL PHARMACEUTICALS, INC. : Material Modification to Rights of Security Hol..
05/27 Cyclacel Announces Reverse Stock Split
05/19 CYCLACEL PHARMACEUTICALS : Seliciclib-Sapacitabine Abstract Selected for Oral Pr..
More news
Sector news : Bio Therapeutic Drugs
07/29DJMerck Revenue Rises on Cancer, Hepatitis Treatments
07/29DJMERCK : Revenue Rises on Cancer, Hepatitis Treatments
07/29DJSanofi Profit Down as Diabetes Drug Sales Slip
07/28DJCELGENE : Lifts Guidance as Revlimid Sales Rise -- Update
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/07 Midday Gainers / Losers
06/06 Midday Gainers / Losers
06/06 Cyclacel's lead product candidates show encouraging results in early-stage st..
06/06 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
06/02 Some Ideas For The Next Celator
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | US23254L3069 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Spiro Rombotis President, Chief Executive Officer & Director
David C. U'Prichard Chairman
Paul McBarron COO, CFO, Secretary, Director & Executive VP
David Glover Chief Scientist
John Michael Middlecott Banham Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYCLACEL PHARMACEUTICA..7.17%15
AMGEN, INC.5.98%129 232
GILEAD SCIENCES, INC.-21.46%105 840
CELGENE CORPORATION-6.32%86 960
REGENERON PHARMACEUTIC..-21.69%44 671
VERTEX PHARMACEUTICALS..-22.91%23 993
More Results